In a 60-year-old African American male with end-stage renal disease who has refused hemodialysis and presents with right-sided chest pain, normal basic metabolic panel and troponin, and a markedly elevated pro‑brain natriuretic peptide of 12,182, what is the recommended management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of ESRD Patient Who Refused Dialysis with Chest Pain and Elevated Pro-BNP

This patient requires immediate supportive care focused on symptom management and hospice referral, as withdrawal from dialysis is ethically acceptable after shared decision-making, and the markedly elevated pro-BNP reflects both volume overload and cardiac dysfunction that cannot be adequately managed without dialysis. 1

Immediate Clinical Assessment

Address the Chest Pain

  • Rule out acute coronary syndrome (ACS) despite normal troponin, as troponin interpretation in ESRD is complex and patients often present atypically for ACS 2
  • Normal troponin does not exclude cardiac ischemia in ESRD patients, who may have microinfarctions, left ventricular hypertrophy, or unrecognized heart failure contributing to symptoms 2
  • Consider ECG and clinical assessment for other causes of right-sided chest pain including pulmonary embolism, pericarditis, or pleuritic pain 2

Interpret the Markedly Elevated Pro-BNP

  • Pro-BNP of 12,182 pg/mL is extremely elevated even for ESRD patients on hemodialysis, where levels are typically elevated but average around 2,000-4,000 pg/mL 3, 4, 5
  • This level indicates severe volume overload and/or significant cardiac dysfunction (heart failure, left ventricular hypertrophy) 4, 5
  • Pro-BNP at this magnitude is a strong predictor of mortality in ESRD patients 4
  • Without dialysis, this pro-BNP level cannot be effectively reduced, as hemodialysis typically decreases pro-BNP by only 30-40% per session, and the underlying cardiac pathology requires ongoing management 4, 6

Management Framework

Respect Patient Autonomy Regarding Dialysis Refusal

  • Withdrawal from dialysis is ethically and clinically acceptable after shared decision-making 1
  • Before accepting the refusal as final, address potentially remedial factors:
    • Screen for depression, as this may be contributing to the refusal 1
    • Assess for inadequately treated pain or other symptoms 1
    • Evaluate for reversible social factors (financial concerns, transportation issues, family support) 1
  • Ensure the patient has decision-making capacity and is making a fully informed, voluntary choice 1

Provide Comprehensive Conservative Care

  • Initiate aggressive symptom management focused on quality of life rather than life prolongation 1
  • For volume overload and dyspnea:
    • Administer intravenous loop diuretics (furosemide starting at 20 mg bolus or 3 mg/h infusion, doubling doses until symptom relief or maximum 160 mg bolus/24 mg/h infusion) 1
    • Recognize that diuretic efficacy will be limited given ESRD and refusal of dialysis 1
    • Consider ultrafiltration or hemofiltration if patient reconsiders dialysis for symptom control 1

Address Cardiac Dysfunction

  • The combination of elevated pro-BNP and right-sided chest pain suggests possible right ventricular dysfunction or acute cor pulmonale 4, 5
  • Echocardiography would help assess left ventricular ejection fraction, left ventricular hypertrophy, and volume status, though management options are limited without dialysis 4, 5
  • Optimize blood pressure control if hypertensive, using agents that don't require renal clearance 1

Initiate Hospice and Palliative Care

  • Ensuring access to appropriate supportive and/or hospice care is an integral part of care following a decision to withdraw dialysis 1
  • Without dialysis, this patient will develop progressive uremia, volume overload, and electrolyte abnormalities leading to death within days to weeks 1
  • Focus on:
    • Pain management for chest pain
    • Dyspnea management with opioids and oxygen as needed
    • Management of nausea, pruritus, and other uremic symptoms
    • Psychosocial and spiritual support 1

Critical Pitfalls to Avoid

  • Do not assume the elevated pro-BNP is "just from renal disease" – this level indicates severe cardiac pathology requiring attention 4, 5
  • Do not dismiss normal troponin as excluding cardiac disease in ESRD patients who often have chronically elevated troponin and atypical presentations 2
  • Do not proceed with conservative management without first addressing reversible factors (depression, pain, social issues) that may be influencing the dialysis refusal 1
  • Do not delay hospice referral once the decision to forgo dialysis is confirmed, as quality of life rapidly deteriorates 1

Prognosis Without Dialysis

  • The extremely elevated pro-BNP (12,182 pg/mL) is strongly predictive of mortality even in patients receiving dialysis 4
  • Without dialysis, death will occur from progressive uremia, volume overload, hyperkalemia, or cardiac complications within approximately 1-2 weeks 1
  • The right-sided chest pain and markedly elevated pro-BNP suggest this patient may have acute cardiac decompensation that could lead to death within days 4, 5

Related Questions

What is the initial workup and management for a patient with elevated troponin (cardiac biomarker) levels, End-Stage Renal Disease (ESRD) and Heart Failure with Reduced Ejection Fraction (HFrEF)?
How do B-type Natriuretic Peptide (BNP) levels get affected in patients with End-Stage Renal Disease (ESRD)?
Can End-Stage Renal Disease (ESRD) elevate troponin levels to 6800?
Can troponin levels be elevated in patients with End-Stage Renal Disease (ESRD)?
Can renal issues cause elevated Troponin (cardiac enzyme) levels?
What is the recommended initial management for a 35-year-old non-diabetic male with a two-week history of difficulty raising his shoulder?
What is the recommended management of a newborn with small bowel obstruction?
What is the likely diagnosis and appropriate management for pruritic hyperpigmented plaques on the elbows and toes in a patient with diabetes and hypertension?
What is the recommended approach to diagnose and manage pneumopericardium?
Are urologic chronic pelvic pain syndrome (UCPPS) and interstitial cystitis (IC) the same condition for diagnosis?
What additional peri‑operative anesthetic concerns should be addressed for a patient with systemic lupus erythematosus who is taking chronic telmisartan (angiotensin‑II receptor blocker), amlodipine (calcium‑channel blocker), carvedilol (beta‑blocker), methylprednisolone (glucocorticoid), rosuvastatin (statin), fenofibrate (fibric acid derivative), hydroxychloroquine (antimalarial), bilastine (antihistamine), pregabalin (gabapentinoid), calcium carbonate, vitamin B, febuxostat (xanthine oxidase inhibitor), and PRN paracetamol (acetaminophen)/tramadol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.